Philip Noone

Philip Noone is a seasoned executive with extensive experience in the diagnostics and bioreagents sectors. Currently serving as Executive Vice President of Diagnostics at Biosynth from July 2023 to March 2025, Philip is responsible for strategic development and P&L for the global diagnostics business, focusing on organic growth and M&A activities. Previously, Philip held key positions such as Managing Director at Aalto Bioreagents Ltd., and Vice President of Sales & Marketing at Trinity Biotech. Philip's career in business development began at Quest Diagnostics, where responsibilities included strategic initiatives for the Molecular Diagnostic and Serology business units across EMEA countries. Academic credentials include a BSc in Marketing from Technological University Dublin and a Diploma in Accounting, Finance, Mergers & Acquisitions from U.C.Dip A.F.